Virpax Pharmaceuticals, Inc. (VRPX)
0.0008
0.00 (0.00%)
USD |
OTCM |
Oct 30, 16:00
Virpax Pharmaceuticals Max Drawdown (5Y) : 100.0% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 100.0% |
| September 30, 2026 | 100.0% |
| August 31, 2026 | 100.0% |
| July 31, 2026 | 100.0% |
| June 30, 2026 | 100.0% |
| May 31, 2026 | 100.0% |
| April 30, 2026 | 100.0% |
| March 31, 2026 | 100.0% |
| February 28, 2026 | 100.0% |
| January 31, 2026 | 100.0% |
| Date | Value |
|---|---|
| December 31, 2025 | 100.0% |
| November 30, 2025 | 100.00% |
| October 31, 2025 | 100.00% |
| September 30, 2025 | 100.00% |
| August 31, 2025 | 100.00% |
| July 31, 2025 | 100.00% |
| June 30, 2025 | 100.00% |
| May 31, 2025 | 100.00% |
| April 30, 2025 | 100.00% |
| March 31, 2025 | 99.98% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Avenir Wellness Solutions, Inc. | 100.00% |
| Acura Pharmaceuticals, Inc. | 100.00% |
| Bright Green Corp. | -- |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 1557.93 |
| Beta (5Y) | -201.68 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 42.40K% |
| Historical Sharpe Ratio (5Y) | -0.0023 |
| Historical Sortino (5Y) | -0.9393 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 96.52% |